Company attributes
Industry
CEO
Founder
Pitchbook URL
Number of Employees (Ranges)
1 – 10
Email Address
info@acrigen.com0
Number of Employees
3
Full Address
626 Bancroft Way, Suite A Berkeley, CA 947100
Investors
DUNS Number
117041283
Founded Date
2019
Latest Funding Round Date
September 28, 2021
Latest Funding Type
Technologies Used
Country
Other attributes
Company Operating Status
Active
Acrigen Biosciences is a biotech company developing technologies to improve efficiency and safety of CRISPR-Cas gene editing through anti-CRISPR proteins, also called Acr proteins. Acr proteins precisely deactivate Cas proteins and serve as a gene editing “off switch”. The company was co-founded by Professor Joseph Bondy-Denomy of UCSF who discovered Acr proteins.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
